Who
Harry Fisch
Chief Corporate Officer
Company insider
Files Form 4 as: Chief Corporate Officer, Veru.
In numbers
- Trades disclosed
- 57
- Buys
- 35
- Sells
- 1
- Bought
- $525K
- Sold
- $835K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 17 May 2017
- Last trade
- 4 May 2026
- Last filed
- 6 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 May 2026filed 6 May 2026 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 5 Dec 2025filed 9 Dec 2025 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 6 May 2025filed 8 May 2025 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —104,000 at $0.00 | filing |
| 24 May 2024filed 28 May 2024 | VERU VeruBiotechnology | SEC FORM 4 Bought | $5,0004,000 at $1.25 | filing |
| 15 May 2024filed 17 May 2024 | VERU VeruBiotechnology | SEC FORM 4 Bought | $9,9996,711 at $1.49 | filing |
| 7 May 2024filed 9 May 2024 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —102,000 at $0.00 | filing |
| 9 May 2023filed 11 May 2023 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 2 Nov 2022filed 4 Nov 2022 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —98,000 at $0.00 | filing |
| 22 Apr 2022filed 25 Apr 2022 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 3 Nov 2021filed 5 Nov 2021 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —133,200 at $0.00 | filing |
| 16 Jun 2021filed 21 Jun 2021 | VERU VeruBiotechnology | SEC FORM 4 Sold | $835K100,000 at $8.35 | filing |
| 13 Nov 2020filed 17 Nov 2020 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,117 at $0.00 | filing |
| 13 Nov 2020filed 17 Nov 2020 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —105,000 at $0.00 | filing |
| 26 Aug 2020filed 27 Aug 2020 | VERU VeruBiotechnology | SEC FORM 4 Bought | $14K5,000 at $2.76 | filing |
| 21 Feb 2020filed 24 Feb 2020 | VERU VeruBiotechnology | SEC FORM 4 Bought | $4,4701,000 at $4.47 | filing |
| 20 Feb 2020filed 21 Feb 2020 | VERU VeruBiotechnology | SEC FORM 4 Bought | $4,5101,000 at $4.51 | filing |
| 14 Nov 2019filed 18 Nov 2019 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —102,000 at $0.00 | filing |
| 14 Nov 2019filed 18 Nov 2019 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —123,552 at $0.00 | filing |
| 3 Sep 2019filed 4 Sep 2019 | VERU VeruBiotechnology | SEC FORM 4 Bought | $19K10,000 at $1.93 | filing |
News
No headline names them, or the companies they trade most, lately.